The study, conducted by the Cardiothoracic Surgical Trials Network sponsored by the National Institutes of Health and the Canadian Institutes of Health Research, enrolled 5,158 adult cardiac surgery patients between February and September 2010 to examine the relationship between transfusion and risk of major infection following cardiac surgery.
"Our study enrolled a large population of patients from a number of different institutions who were undergoing any type of cardiac surgery," said lead author Keith A. Horvath, MD, from the National Heart, Lung and Blood Institute in Bethesda, Md. "This large patient set enabled us to better examine the relationship between transfusion and infection in a very diverse population. However, because this is an observational study, the reported associations cannot be considered causal."
Among the patients in the study, RBCs were transfused in 2,481 (48%), and platelets were transfused in 1,599 (31%). The highest volume of RBCs was given during transplant or left ventricular assist device implantation (84%) and thoracic aortic procedures (63%), while the lowest volumes were given for isolated coronary artery bypass grafting surgery (45%) and isolated valve surgery (40%).
Within 65 days following surgery, 235 patients (5 percent) were diagnosed with one or more major infections, the most common being pneumonia, C. difficile colitis (bacterial infection in the colon), and bloodstream infections.
The authors found a dose-related association between the quantity of RBCs transfused and the unadjusted risk of infection, with a 29% increase in infection with each RBC unit transfused. Conversely, a lower risk of infection was observed when platelets were also transfused in conjunction with more than four units of RBCs.
"A common problem for many surgeons, and thereby the patient, is how to balance the risk of surgery-induced anemia with the increased risk of infection when using red blood cell transfusion to correct the anemia," added Dr. Horvath. "Through this study we hoped to shed light on the problem and to encourage hospitals and surgeons to examine cell-salvage techniques and other alternatives to RBC transfusion during and after cardiac surgery."
Cardiac surgery has the highest consumption of blood products of any field in medicine, with half of patients undergoing cardiac surgery receiving blood products, according to background information in the study. Blood transfusion, while believed to be lifesaving, can carry substantial adverse risks. All benefits and risks of transfusion should be discussed between the patient and the cardiac surgery team, and must be weighed against risks of anemia, which also is associated with adverse outcomes, according to the researchers.
Cardiac Surgery Teams Should Embrace Transfusion, Blood Management Guidelines
In an editorial in the same issue, Bruce D. Spiess, MD, from Virginia Commonwealth University Medical Center in Richmond, commented on the conflicting messages in the medical community surrounding blood transfusion. "Few in regulatory agencies have grasped the complex but real relationships between red cell transfusions, infection â€¦ and readmissions," he wrote. "We in cardiac surgery/anesthesia/perfusion have led by creating/publishing guidelines for transfusion and blood management, thereby demonstrating a leadership understanding of this important area. Even though the cardiac team leads the way in publishing guidelines a small minority of our colleagues have read and adopted these 'best practices''."
Dr. Spiess encouraged surgical teams to work together to mitigate problems resulting from blood transfusions. "Today it is time for all cardiac teams to come together as teams embracing blood management," he wrote. "The data presented in this issue suggests that by doing so not only will cardiac surgery improve patient safety, decrease hospital-acquired infections but they will single-handedly reduce critical blood shortages."
: STS guidelines, including blood conservation guidelines, are available at www.sts.org/guidelines
For a copy of the study or editorial, contact Cassie Brasseur at 312-202-5865 or email@example.com
Founded in 1964, The Society of Thoracic Surgeons is a not-for-profit organization representing more than 6,600 cardiothoracic surgeons, researchers, and allied health care professionals worldwide who are dedicated to ensuring the best possible outcomes for surgeries of the heart, lung, and esophagus, as well as other surgical procedures within the chest. The Society''s mission is to enhance the ability of cardiothoracic surgeons to provide the highest quality patient care through education, research and advocacy.
The Annals of Thoracic Surgery
is the official journal of STS and the Southern Thoracic Surgical Association.